| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/06/2001 | CA2155872C Oxytocin antagonist |
| 02/06/2001 | CA2106612C Displacement chromatography process |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2003538C Collagen-polymer conjugates |
| 02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
| 02/01/2001 | WO2001007918A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | WO2001007917A1 Determining antibodies to ny-eso-1 in cancer patients |
| 02/01/2001 | WO2001007914A1 Fenretinide increases antibody cellular toxicity |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007656A1 Antisense modulation of shp-1 expression |
| 02/01/2001 | WO2001007655A1 Antisense modulation of shp-2 expression |
| 02/01/2001 | WO2001007631A2 Novel glycosyltransferase, the production thereof and its use |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007627A1 Drosophila recombination-associated protein and methods for use |
| 02/01/2001 | WO2001007625A2 Ehrlichia canis genes and vaccines |
| 02/01/2001 | WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007610A1 Pmf-1 (polyamide-modulated factor 1) |
| 02/01/2001 | WO2001007608A1 Keratinocyte derived interferon |
| 02/01/2001 | WO2001007604A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | WO2001007602A2 Oligonucleotides for inhibiting the expression of human eg5 |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007594A1 Antisense modulation of mekk1 expression |
| 02/01/2001 | WO2001007486A1 A biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007480A2 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 02/01/2001 | WO2001007477A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007474A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association |
| 02/01/2001 | WO2001007473A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 02/01/2001 | WO2001007472A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007468A2 Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
| 02/01/2001 | WO2001007467A1 Streptogramin derivatives, preparation and compositions containing same |
| 02/01/2001 | WO2001007466A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | WO2001007465A1 Ga1R |
| 02/01/2001 | WO2001007463A1 Trer |
| 02/01/2001 | WO2001007461A1 Antisense modulation of mekk5 expression |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007458A1 lacR |
| 02/01/2001 | WO2001007457A1 Antisense modulation of pten expression |
| 02/01/2001 | WO2001007456A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 02/01/2001 | WO2001007442A1 Beta-amyloid peptide inhibitors |
| 02/01/2001 | WO2001007419A1 Novel thiazine or pyrazine derivatives |
| 02/01/2001 | WO2001007407A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 02/01/2001 | WO2001007405A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 02/01/2001 | WO2001007085A1 Novel methods and reagents useful in the treatment of osteoarthritis |
| 02/01/2001 | WO2001007081A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 02/01/2001 | WO2001007078A1 Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases |
| 02/01/2001 | WO2001007077A1 Antiulcer agents |
| 02/01/2001 | WO2001007076A1 Use of interleukin-11 to treat gastrointestinal disorders |
| 02/01/2001 | WO2001007075A2 Multi-dose erythropoietin formulations |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007072A1 Modulation of platelet activation |
| 02/01/2001 | WO2001007071A1 Composition and method for enhancing wound healing |
| 02/01/2001 | WO2001007068A1 Novel methods and reagents for the treatment of osteoarthritis |
| 02/01/2001 | WO2001007067A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2001007064A1 Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions |
| 02/01/2001 | WO2001007059A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2001 | WO2001007056A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 02/01/2001 | WO2001007042A1 Apicidin-derived cyclic tetrapeptides |
| 02/01/2001 | WO2001007006A1 Association of fibrillin and a cyanophyta extract, preparation method and use as medicine |
| 02/01/2001 | WO2001006989A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006843A2 Promotion of proliferation of adult corneal endothelial cells |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000066720A3 The use of adeno-associated virus (aav) deliver cytoprotective genes |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000063248A3 Highly purified gonadotropin compositions and process for preparing them |
| 02/01/2001 | WO2000061175A3 Use of pegylated interferon alpha in melanoma therapy |
| 02/01/2001 | WO2000053756A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000052047A3 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 02/01/2001 | WO2000051583A3 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000040226A3 Method of treating sexual disturbances |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | WO2000011035A9 Hiv suppressor factor derived from scrub typhus |
| 02/01/2001 | WO2000003743A3 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 02/01/2001 | WO1999061040A9 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
| 02/01/2001 | DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments |
| 02/01/2001 | DE19935663A1 Transfecting human chromosome 7 into Escherichia coli, useful for generating products for treatment of cystic fibrosis |
| 02/01/2001 | DE19935508A1 Producing a glycoprotein product that stimulates tumor necrosis factor alpha production, useful for treating cancer and viral infections, comprises culturing Rhodococcus fascians |
| 02/01/2001 | DE19934458A1 Composition for treating pigmentation disorders, e.g. vitiligo, containing the protein DCoH, or related nucleic acids, antibodies or antisera |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | DE10022687A1 Gene-transfer vector containing an enhancer-promoter, useful for prevention or treatment of tumors, is able to enter normal tissue to prevent metastasis |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |